Skip to main content
. 2005 Jun;49(6):2565–2567. doi: 10.1128/AAC.49.6.2565-2567.2005

TABLE 1.

MICs of β-lactams for B. bronchiseptica DOR, B. parapertussis CIP 63.33, E. coli DH10B harboring recombinant plasmid pFL-1 expressing BOR-1 from B. bronchiseptica DOR, and the E. coli DH10B reference strain

β-Lactam(s)b MIC (μg/ml) for:
B. bronchiseptica DOR B. parapertussis CIP 63.33a E. coli DH10B (pFL-1)a E. coli DH10B
Amoxicillin 8 2 512 2
Amoxicillin + CLA 2 0.12 8 2
Ticarcillin 8 2 512 1
Ticarcillin + CLA 2 <0.06 64 1
Piperacillin 0.25 <0.06 8 1
Piperacillin + TZB 0.06 <0.06 4 1
Cephalothin 8 8 4 2
Imipenem 0.25 0.25 0.25 0.25
Cefoxitin 512 64 2 2
Cefuroxime 512 2 4 2
Cefotaxime 512 0.5 <0.06 <0.06
Ceftazidime 16 <0.06 <0.06 <0.06
Cefepime 16 <0.06 <0.06 <0.06
Cefpirome 512 <0.06 <0.06 <0.06
Aztreonam 512 0.06 0.06 0.06
Moxalactam 1 0.12 0.12 0.12
a

B. parapertussis CIP 63.33 and E. coli DH10B (pFL-1) produced β-lactamase BOR-1.

b

CLA, clavulanic acid at a fixed concentration of 2 μg/ml; TZB, tazobactam at a fixed concentration of 4 μg/ml.